Results 21 to 30 of about 41,992 (300)
Periventricular remyelination failure in multiple sclerosis: a substrate for neurodegeneration.
In multiple sclerosis, spontaneous remyelination is generally incomplete and heterogenous across patients. A high heterogeneity in remyelination may also exist across lesions within the same individual, suggesting the presence of local factors ...
Matteo Tonietto+7 more
semanticscholar +1 more source
Motor Learning Promotes Remyelination via New and Surviving Oligodendrocytes
Oligodendrocyte loss in neurological disease leaves axons vulnerable to damage and degeneration, and activity-dependent myelination may represent an endogenous mechanism to improve remyelination following injury.
Clara M. Bacmeister+6 more
semanticscholar +1 more source
Primary Progressive Multiple Sclerosis: New Therapeutic Approaches. [PDF]
Primary progressive MS affects 10%–15% of MS patients, causing irreversible neurological impairment. Drugs like ocrelizumab show promise, while high‐dose biotin, simvastatin, and coenzyme Q10 are under investigation. Gene therapy and stem cell treatments also show potential.
Rajabi M+8 more
europepmc +2 more sources
Multiple sclerosis (MS) is an inflammatory, demyelinating, and neurodegenerative disease of the central nervous system (CNS) triggered by autoimmune mechanisms.
Francesca Cignarella+19 more
semanticscholar +1 more source
Glial cells play crucial roles in brain homeostasis and pathogenesis of central nervous system (CNS) injuries and diseases. However, the roles of these cells and the molecular mechanisms toward regeneration in the CNS have not been fully understood ...
Lili Quan, Akiko Uyeda, R. Muramatsu
semanticscholar +1 more source
Delayed Demyelination and Impaired Remyelination in Aged Mice in the Cuprizone Model
To unravel the failure of remyelination in multiple sclerosis (MS) and to test promising remyelinating treatments, suitable animal models like the well-established cuprizone model are required. However, this model is only standardized in young mice. This
Stefan Gingele+7 more
doaj +1 more source
Remyelination failure in multiple sclerosis (MS) contributes to progression of disability. The deficient repair results from neuroinflammation and deposition of inhibitors including chondroitin sulfate proteoglycans (CSPGs).
S. Ghorbani+16 more
semanticscholar +1 more source
Demyelination in MS disrupts nerve signals and contributes to axon degeneration. While remyelination promises to restore lost function, it remains unclear whether remyelination will prevent axonal loss.
Feng Mei+16 more
doaj +1 more source
A higher proportion of ermin-immunopositive oligodendrocytes in areas of remyelination.
Incomplete remyelination is frequent in multiple sclerosis (MS)-lesions, but there is no established marker for recent remyelination. We investigated the role of the oligodendrocyte/myelin protein ermin in de- and remyelination in the cuprizone (CPZ ...
Intakhar Ahmad+3 more
doaj +1 more source
Increased Remyelination and Proregenerative Microglia Under Siponimod Therapy in Mechanistic Models
Background and Objectives Siponimod is an oral, selective sphingosine-1-phosphate receptor-1/5 modulator approved for treatment of multiple sclerosis. Methods Mouse MRI was used to investigate remyelination in the cuprizone model.
Michael Dietrich+26 more
semanticscholar +1 more source